Intramedullary Spinal Cord Metastasis in Spinal Ependymomas

Area of Science:

• Neurology
• Oncology
• Neurosurgery

Background:

• Drop metastasis, or intramedullary spinal cord metastasis (ISCM), is a rare form of central nervous system (CNS) metastasis, comprising 0.9%-5% of all spinal metastases.
• This condition results from tumor cell dissemination via cerebrospinal fluid (CSF), frequently impacting the thoracic and lumbar spine.
• ISCM presents with rapidly progressive neurological deficits, including limb weakness, sensory loss, and pain, posing diagnostic challenges.

Purpose of the Study:

• To review the incidence, clinical presentation, diagnostic modalities, and treatment strategies for intramedullary spinal cord metastasis (ISCM).
• To highlight the diagnostic challenges and emphasize the role of MRI in identifying ISCM.
• To outline the current primary and palliative treatment options for ISCM.

Main Methods:

• Literature review of studies on intramedullary spinal cord metastasis (ISCM).
• Analysis of diagnostic imaging, particularly MRI with gadolinium.
• Evaluation of treatment outcomes for surgical resection, radiotherapy, and chemotherapy.

Main Results:

• ISCM is a rare but serious complication of CNS or spinal metastases.
• MRI with gadolinium is the gold standard for diagnosing ISCM.
• Surgical resection combined with radiotherapy is the main treatment, with chemotherapy used palliatively.

Conclusions:

• Intramedullary spinal cord metastasis (ISCM) requires prompt diagnosis and management.
• Multimodal treatment including surgery and radiotherapy offers the best outcomes.
• Further research is needed to optimize chemotherapy's role in managing recurrent or disseminated ISCM.